A carregar...
Reactions to learning a “not elevated” amyloid PET result in a preclinical Alzheimer’s disease trial
BACKGROUND: The experiences of biomarker-ineligible cognitively normal persons can inform trial conduct and the translation of preclinical Alzheimer’s disease (AD) into clinical practice. METHODS: We interviewed 33 persons whose “not elevated” brain amyloid imaging biomarker result made them ineligi...
Na minha lista:
| Publicado no: | Alzheimers Res Ther |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6303934/ https://ncbi.nlm.nih.gov/pubmed/30579361 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13195-018-0452-1 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|